Last updated: July 20, 2026

Does Cigna Cover Depression Treatment in Maine? A 2026 Guide

If you have Cigna health insurance in Maine and you are wondering whether your plan may cover depression treatment, the short answer is: yes, Cigna plans in Maine are generally required to include behavioral health benefits that may cover depression care. Maine’s mental health parity law. Me. Rev. Stat. Ann. tit. 24-A, § 2749-A. Requires commercial fully-insured plans to cover mental health conditions, including depression, at parity with medical and surgical benefits. Understanding exactly what your plan covers, how prior authorization works, and what Maine’s e-prescribing rules mean for your treatment can make a significant difference in accessing the care you need.

Ready to connect with a licensed provider?
Klarity Health has 2,000+ licensed providers in Maine and across the U.S. who accept Cigna and can evaluate and treat depression via telehealth.

See If You May Qualify. Check Your Coverage

Quick Facts: Cigna Depression Coverage in Maine

• Insurer: Cigna Health and Life Insurance Company
• PBM (Pharmacy Benefits): Express Scripts (ESI)
• Maine Parity Law: Me. Rev. Stat. Ann. tit. 24-A, § 2749-A. Applies to depression
• Cigna PA Policy IP0477: Stimulant-only. Does NOT apply to antidepressants
• Maine EPCS: Standard antidepressants are non-scheduled. EPCS entirely inapplicable. Spravato (esketamine, Schedule III). EPCS REQUIRED.
• Key contacts: Cigna Member Services 1-800-244-6224 | Express Scripts 1-800-835-3784 | Maine Bureau of Insurance 1-800-300-5000

Maine Mental Health Parity Law (§ 2749-A) and Depression

Maine’s mental health parity statute. Me. Rev. Stat. Ann. tit. 24-A, § 2749-A. Is a key protection for Mainers with depression who have commercial, fully-insured health insurance through Cigna. The law requires that:

• Financial requirements (copays, deductibles, out-of-pocket maximums) for mental health benefits, including depression treatment, cannot be more restrictive than those applied to medical and surgical benefits.
• Treatment limitations (visit limits, day limits, frequency restrictions) cannot be more restrictive for mental health than for analogous medical benefits.
• Non-quantitative treatment limitations (NQTLs). Such as prior authorization criteria, step therapy protocols, and network adequacy standards. Must be comparable in scope and application.
• Telehealth: Maine law requires insurers to cover telehealth services at parity with in-person visits, which is important for patients accessing depression treatment remotely.

Important note for self-funded employer plans: If your Cigna coverage comes through a large employer that self-insures, Maine’s § 2749-A may not apply directly. Self-funded plans are governed by ERISA and the federal Mental Health Parity and Addiction Equity Act (MHPAEA). MHPAEA provides similar parity protections at the federal level. If you are unsure whether your plan is fully-insured or self-funded, check your Summary Plan Description (SPD) or call Cigna at 1-800-244-6224.

What Depression Benefits May Be Available Under Cigna in Maine

Most Cigna plans in Maine that comply with § 2749-A and the ACA may include the following depression-related benefits:

• Outpatient therapy: Individual therapy, cognitive behavioral therapy (CBT), and other evidence-based modalities for major depressive disorder (MDD) and related conditions
• Psychiatric evaluation and medication management: Initial diagnostic evaluation and ongoing prescription management with a licensed psychiatrist or psychiatric nurse practitioner
• Telehealth depression treatment: Virtual visits with licensed providers, covered at parity with in-person care under Maine law
• Intensive outpatient programs (IOP) and partial hospitalization programs (PHP): For moderate-to-severe depression that requires more structured support than weekly therapy
• Inpatient psychiatric hospitalization: For acute depressive episodes requiring 24-hour care
• ACA preventive services: Under the ACA, Cigna plans must cover depression screening (PHQ-9 and similar tools) at no cost-sharing as a preventive service for adults
• Prescription drug coverage: Antidepressant medications covered through Express Scripts (see formulary section below)

Coverage varies by plan. Always verify your specific benefits by calling Cigna Member Services at 1-800-244-6224 or reviewing your Summary of Benefits and Coverage (SBC).

Cigna PA Policy IP0477. Does It Apply to Depression Medications?

Cigna’s prior authorization policy IP0477 (effective May 15, 2026) requires prior authorization for all stimulant medications. Including generics. If you have read about IP0477 in relation to ADHD coverage, you may be wondering whether it affects antidepressants. It does not.

IP0477 is a stimulant-only policy. It applies exclusively to stimulant medications such as amphetamine salts (Adderall, Vyvanse), methylphenidate (Ritalin, Concerta), and similar Schedule II controlled substances used to treat ADHD. Standard antidepressants. Including SSRIs, SNRIs, bupropion, mirtazapine, tricyclics, and MAOIs. Are not affected by IP0477.

This is an important distinction for patients receiving or seeking depression treatment. Your antidepressant prescription process under Cigna/ESI follows standard formulary tier and PA criteria, not the IP0477 stimulant protocol.

Express Scripts (ESI) Antidepressant Formulary. Maine 2026

Cigna uses Express Scripts (ESI) as its pharmacy benefits manager in Maine. The table below outlines how common antidepressants are typically covered under ESI formulary tiers. Actual tier placement may vary by specific plan; always confirm with ESI at 1-800-835-3784 or via the ESI online formulary tool.

Tier placements are estimates based on ESI standard formulary guidelines for 2026. Your specific plan may differ. Call Express Scripts at 1-800-835-3784 to confirm tier, PA requirements, and step therapy criteria for your plan.

Maine EPCS Rules for Antidepressants. What Telehealth Patients Need to Know

Maine has broad Electronic Prescribing of Controlled Substances (EPCS) requirements under its pharmacy law (Schedule II. V). However, for most patients seeking depression treatment in Maine, EPCS is not a concern. Because virtually all standard antidepressants are non-scheduled (not controlled substances) and EPCS does not apply to them.

Practical takeaway: For the vast majority of patients seeking depression treatment in Maine. Including those receiving SSRIs, SNRIs, bupropion, mirtazapine, or even Trintellix. Maine’s EPCS requirement is entirely inapplicable. Telehealth providers who can prescribe electronically can handle these prescriptions without any controlled substance EPCS certification. The only exception is Spravato (esketamine nasal spray), which is a Schedule III controlled substance and therefore subject to Maine’s EPCS mandate. However, Spravato is a specialty treatment for treatment-resistant depression (TRD) that is administered in a certified healthcare setting, not typically a standard telehealth prescription.

Spravato (Esketamine). Special Considerations Under Cigna/ESI

Spravato (esketamine nasal spray) is FDA-approved for treatment-resistant depression (TRD). Defined as major depressive disorder that has not adequately responded to at least two different antidepressant treatments. And for major depressive disorder with acute suicidal ideation or behavior (MDSI).

Under Cigna/ESI in Maine, Spravato coverage typically requires:

• Prior authorization (PA): Required before dispensing. ESI and Cigna must approve the prescription based on clinical criteria.
• Step therapy: Documentation of at least two adequate antidepressant trials (adequate dose and duration, typically 6. 8 weeks each) that failed to produce sufficient response.
• REMS program: Spravato is subject to a Risk Evaluation and Mitigation Strategy (REMS). It must be administered in a certified healthcare setting with a minimum 2-hour observation period. It cannot be taken at home or dispensed via a standard mail-order pharmacy.
• Maine EPCS: Spravato is a Schedule III controlled substance. Prescribers in Maine must use a compliant EPCS system when prescribing Spravato under Maine law.
• Tier 4 specialty: Cost-sharing is at the specialty tier, which typically has the highest cost-sharing level before meeting your out-of-pocket maximum.

If you believe you may qualify for Spravato, speak with your prescribing provider about whether your history of antidepressant trials meets the PA criteria and whether a certified Spravato treatment center is accessible in your area.

Prior Authorization for Antidepressants Under Cigna/ESI

Most generic first-line antidepressants (SSRIs, SNRIs, bupropion, mirtazapine) do not require prior authorization under standard ESI formulary tiers and may be filled immediately after your provider submits the prescription. However, certain brand-name or newer antidepressants may require PA or step therapy documentation.

Common situations that trigger PA or step therapy:

• Trintellix (vortioxetine): Step therapy typically requires documentation of a prior SSRI or SNRI trial. If sertraline or escitalopram was tried and not tolerated or not effective, that typically satisfies the step therapy requirement.
• Auvelity (bupropion/dextromethorphan): PA required. Criteria typically include prior antidepressant treatment history and a diagnosis of MDD.
• Spravato (esketamine): PA required with 2+ failed antidepressant trials, plus REMS certification of treatment center.
• Brand SSRIs/SNRIs: If a brand version is prescribed when a generic is available (e.g., brand Lexapro when generic escitalopram is available), PA may be required for the brand.

If PA is required, your prescribing provider typically submits the PA request to ESI directly. Allow 1. 3 business days for standard PA decisions and up to 72 hours for urgent/expedited reviews.

How to Verify Your Cigna Depression Benefits in Maine

1. Call Cigna Member Services: 1-800-244-6224. Ask specifically about your behavioral health benefits for outpatient depression treatment, telehealth parity, and any prior authorization requirements for your specific plan.
2. Call Express Scripts: 1-800-835-3784. Ask about the formulary tier and PA requirements for any specific antidepressant your provider has recommended.
3. Review your Summary of Benefits and Coverage (SBC): Your SBC outlines copay amounts, deductibles, and cost-sharing for mental health benefits. It is available through your employer’s HR portal or the Cigna member portal at mycigna.com.
4. Check the ESI online formulary tool: Available via express-scripts.com or through the myCigna portal. You can search by drug name to see tier placement and any coverage requirements.
5. Contact the Maine Bureau of Insurance: 1-800-300-5000. If you believe your plan is improperly denying depression coverage or applying more restrictive requirements than for medical benefits, the Maine Bureau of Insurance can assist with complaints and parity enforcement.

How to Appeal a Denial of Depression Treatment or Medication

If Cigna or ESI denies a prior authorization, step therapy exception, or claim for depression treatment, you have the right to appeal. Maine law and federal law provide robust appeal rights.

1. Request a peer-to-peer (P2P) review: Your prescribing provider can call Cigna’s clinical review team to discuss the clinical rationale for the denied treatment directly with the reviewing physician. P2P calls often result in overturned denials.
2. File an internal appeal: Submit a written internal appeal with supporting clinical documentation. Cigna must respond within 30 days for standard appeals and 72 hours for urgent/expedited appeals.
3. Request a step therapy exception: If step therapy is the basis for denial, your provider can submit a step therapy exception request documenting why the required step therapy medications are clinically inappropriate, have been tried and failed, or would cause adverse effects.
4. File a parity complaint: If you believe the denial violates Maine’s § 2749-A parity law, you can file a complaint with the Maine Bureau of Insurance at 1-800-300-5000. For self-funded ERISA plans, contact the U.S. Department of Labor’s Employee Benefits Security Administration (EBSA) at 1-866-444-3272.
5. Request an external independent medical review (IMR): After exhausting the internal appeal process, Maine residents may request an external review by an independent organization. The Maine Bureau of Insurance oversees the external review process for fully-insured plans.

Getting Depression Treatment Through Klarity Health With Cigna

Klarity Health is a telehealth platform with 2,000+ licensed providers across Maine and the U.S. who specialize in mental health and psychiatric care, including evaluation and treatment of depression. Klarity’s providers include psychiatrists, psychiatric nurse practitioners, and licensed therapists who can conduct evaluations and prescribe antidepressant medications via telehealth.

How Klarity can help Cigna members in Maine:

• Insurance verification: Klarity’s team can help verify whether your Cigna plan may cover telehealth psychiatric visits and antidepressant medication management before your first appointment.
• EPCS-capable prescribing: While standard antidepressants are non-scheduled and EPCS-inapplicable, all Klarity providers use compliant electronic prescribing platforms as a standard practice.
• Prior authorization support: If your antidepressant requires PA or step therapy documentation, Klarity providers can submit the necessary clinical information to ESI and Cigna on your behalf.
• Parity law guidance: Klarity’s team is familiar with Maine’s § 2749-A requirements and can help patients understand their rights if coverage is improperly denied.
• Fast access: Appointments are typically available within days, not weeks. A meaningful advantage for patients experiencing depressive episodes who cannot wait months for an in-person appointment.

See if your Cigna plan may cover depression treatment at Klarity Health.

Check If You May Qualify

Frequently Asked Questions

Does Cigna cover antidepressants in Maine?

Yes, most Cigna plans in Maine that include prescription drug benefits through Express Scripts may cover antidepressant medications. Generic first-line antidepressants (SSRIs, SNRIs, bupropion, mirtazapine) are typically Tier 1. 2 with no prior authorization. Brand or newer antidepressants like Trintellix or Auvelity may require PA or step therapy. Coverage varies by plan. Verify with ESI at 1-800-835-3784.

Does Cigna’s PA policy IP0477 affect antidepressants?

No. IP0477 is a stimulant-only prior authorization policy that applies exclusively to ADHD medications (Schedule II controlled stimulants). It does not affect antidepressants, anti-anxiety medications, or any other class of psychiatric drugs.

Do antidepressants require EPCS in Maine?

No. Standard antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, Trintellix, Auvelity, TCAs) are non-scheduled drugs and Maine’s EPCS mandate is entirely inapplicable to them. The only exception is Spravato (esketamine), which is a Schedule III controlled substance and does require EPCS in Maine.

Does Maine’s parity law (§ 2749-A) cover depression treatment?

Yes. Me. Rev. Stat. Ann. tit. 24-A, § 2749-A applies to depression and other mental health conditions in commercial, fully-insured plans. It requires that Cigna provide depression benefits at parity with medical and surgical benefits. Including comparable cost-sharing, visit limits, and non-quantitative treatment limitations. Self-funded ERISA plans are governed by federal MHPAEA rather than § 2749-A, but receive similar parity protections.

Can I get depression treatment via telehealth with Cigna in Maine?

Yes. Maine law requires coverage of telehealth services at parity with in-person care. Most Cigna plans in Maine cover telehealth psychiatric visits and medication management for depression at the same cost-sharing as in-person visits. Verify telehealth parity benefits by calling Cigna at 1-800-244-6224.

What if Cigna denies my antidepressant prior authorization?

If ESI or Cigna denies a PA for an antidepressant, your provider can request a peer-to-peer (P2P) review, which frequently leads to overturned denials. You can also file an internal appeal within 30 days of the denial. If you believe the denial violates § 2749-A parity requirements, contact the Maine Bureau of Insurance at 1-800-300-5000.

Key Contacts

• Cigna Member Services: 1-800-244-6224
• Express Scripts (ESI): 1-800-835-3784
• Maine Bureau of Insurance: 1-800-300-5000
• Maine DHHS: 1-800-977-6740
• U.S. DOL EBSA (ERISA/MHPAEA): 1-866-444-3272
• CMS: 1-800-633-4227

Coverage disclaimer: Insurance coverage for depression treatment varies by plan, employer, and individual circumstances. This article provides general information about how Cigna plans in Maine may cover depression treatment and is not a guarantee of benefits. Always verify your specific coverage by contacting Cigna Member Services, reviewing your Summary of Benefits and Coverage, and consulting with your licensed healthcare provider before beginning treatment. Coverage determination is solely the responsibility of your insurer.